WI
AGN

Wintrust Investments’s Allergan plc AGN Stock Holding History

Wintrust Investments’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,828
Closed -$414K – 383
2019
Q1 		$414K Sell
2,828
-2,390
-46% -$347K 0.07% 228
2018
Q4 		$697K Sell
5,218
-2,995
-36% -$491K 0.13% 138
2018
Q3 		$1.56M Sell
8,213
-2,478
-23% -$455K 0.25% 78
2018
Q2 		$1.78M Buy
10,691
+2,934
+38% +$471K 0.31% 57
2018
Q1 		$1.45M Buy
+7,757
New +$1.3M 0.37% 49
2017
Q4 		– Sell
-1,129
Closed -$231K – 289
2017
Q3 		$231K Sell
1,129
-219
-16% -$50.9K 0.06% 248
2017
Q2 		$328K Sell
1,348
-378
-22% -$88.8K 0.09% 218
2017
Q1 		$412K Sell
1,726
-35
-2% -$8.15K 0.12% 185
2016
Q4 		$370K Sell
1,761
-1,755
-50% -$364K 0.15% 131
2016
Q3 		$810K Sell
3,516
-619
-15% -$151K 0.37% 45
2016
Q2 		$56K Buy
+4,135
New +$953K 0.11% 80

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wintrust Investments's AGN Position: Q2 2019 in Review

Wintrust Investments sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 2,828 shares — an estimated $414K sold.

Wintrust Investments first reported a position in AGN in Q2 2016 and held it in 11 quarters. The position peaked at $1.78M in Q2 2018. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Wintrust Investments reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Wintrust Investments sold 2,828 Allergan plc shares in Q2 2019, an estimated $414K.
  • Wintrust Investments first reported a position in Allergan plc in Q2 2016 and held it in 11 quarters.
  • Wintrust Investments's Allergan plc position peaked at $1.78M in Q2 2018.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Wintrust Investments's 13F filing for Q2 2019, filed 5 Aug 2019.